Collins Helen Louise
CHIEF MEDICAL OFFICER
CIK: 1701247
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 1,133 | $44.74 | $50,693.82 | View Details Filing |
| Jun 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 2,599 | $43.87 | $114,018.39 | View Details Filing |
| Jun 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 1,268 | $42.83 | $54,304.64 | View Details Filing |
| May 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 3,475 | $39.53 | $137,380.65 | View Details Filing |
| May 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 223 | $41.21 | $9,188.76 | View Details Filing |
| May 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 1,302 | $40.25 | $52,401.98 | View Details Filing |
| Apr 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 2,441 | $48.06 | $117,303.48 | View Details Filing |
| Apr 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 2,419 | $47.39 | $114,635.44 | View Details Filing |
| Apr 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 140 | $45.81 | $6,413.50 | View Details Filing |